Attached files
| file | filename |
|---|---|
| 10-Q - 10-Q - TREACE MEDICAL CONCEPTS, INC. | d513422d10q.htm |
| EX-32.2 - EX-32.2 - TREACE MEDICAL CONCEPTS, INC. | d513422dex322.htm |
| EX-31.2 - EX-31.2 - TREACE MEDICAL CONCEPTS, INC. | d513422dex312.htm |
| EX-31.1 - EX-31.1 - TREACE MEDICAL CONCEPTS, INC. | d513422dex311.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Treace Medical Concepts, Inc. (the “Company”) on Form 10-Q for the period ending March 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
| Date: May 25, 2021 |
By: |
/s/ John T. Treace | ||
|
| ||||
| John T. Treace | ||||
| Chief Executive Officer (Principal Executive Officer) |